Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
05/2011
05/18/2011CN102060783A Method for preparing 2-substituted-5-nitro-4,6-dichloropyrimidine
05/18/2011CN102060782A Method for preparing chloropyrimidines or analogues thereof
05/18/2011CN101486685B Microwave extracting process for 4(3H) quinazolone in dyers woad leaf
05/17/2011US7943776 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
05/17/2011US7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases
05/17/2011US7943629 Anticancer/antitumor agents; S-(4-([4-([(1R,2R)-2-Hydroxy-1-methylpropyl]amino)-5-(trifluoromethyl)-pyrimidin-2-yl]amino)phenyl)-S-methyl-N-[(trifluoromethyl)sulphonyl]-sulphimide for example
05/17/2011US7943628 Pyrimidine derivatives
05/17/2011US7943627 2,4-diaminopyrimidine derivatives
05/17/2011US7943208 Materials and methods for the preparation of anisotropically-ordered solids
05/17/2011CA2453418C Variolin derivatives and their use as antitumor agents
05/12/2011WO2011056957A2 Enzyme inhibiting compounds
05/12/2011WO2011055914A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/12/2011WO2011055843A1 Retinoid compound
05/12/2011WO2010151710A3 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
05/12/2011WO2008079988A9 Quinazolines for pdk1 inhibition
05/12/2011US20110112294 1-[2', 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors
05/12/2011US20110112126 Enzyme inhibiting compounds
05/12/2011US20110112121 Pharmaceutical Compositions and Solid Forms
05/12/2011US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy
05/12/2011US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods
05/12/2011US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
05/12/2011US20110112062 Carbamate And Urea Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
05/12/2011US20110112060 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
05/12/2011US20110108755 Heteroaromatic phthalonitriles
05/12/2011CA2780149A1 Ire-1.alpha. inhibitors
05/12/2011CA2780128A1 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
05/12/2011CA2779989A1 Quinazoline compounds
05/12/2011CA2779642A1 Enzyme inhibiting compounds
05/11/2011EP2319839A1 Quinazolinone derivatives and their use as CB agonists
05/11/2011EP2318378A2 Quinazoline derivatives
05/11/2011EP2318377A1 Pyrimidine compounds, compositions and methods of use
05/11/2011EP2318374A2 Insecticidal benzenedicarboxamide derivative
05/11/2011EP2220053B1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists
05/11/2011EP2042171B1 Therapeutic or prophylactic agent for allergic dermatitis
05/11/2011EP1763517B1 Pyrimidine derivatives as 11beta-hsd1 inhibitors
05/11/2011EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
05/11/2011EP1320520B1 Sulfonylguanidine
05/11/2011CN102056905A Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
05/11/2011CN102050793A 4(3H) quinazolinone derivatives with antitumor activity
05/11/2011CN102050792A 2-[(substituted phenylamino) carboxyl methylmercapto]-6-aryl-3H-pyrimidine-4-ketone derivative as well as preparation method and application thereof
05/11/2011CN101190897B Method for synthesizing 4-(4-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-formic acid ester
05/10/2011USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them
05/10/2011US7939540 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives
05/10/2011US7939539 Quinazolinone compounds as anticancer agents
05/10/2011US7939538 Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
05/10/2011US7939537 HIV integrase inhibitors
05/10/2011US7939527 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase
05/10/2011US7939523 Imidazolidinone and imidazolidinethione derivatives
05/05/2011WO2011053701A1 Phenoxy-substituted pyrimidines as opioid receptor modulators
05/05/2011WO2011053510A1 Heterocyclyl substituted arylindenopy-rimidines and their use as highly selective adenosine a2a receptor antagonists
05/05/2011WO2011053509A1 Aryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists
05/05/2011WO2011051425A1 N-oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea
05/05/2011WO2011051282A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
05/05/2011WO2011051201A1 Positive allosteric modulators (pam)
05/05/2011WO2011025938A3 Raf inhibitor compounds and methods of use thereof
05/05/2011WO2005060456A9 Method for treating adamts-5-associate disease
05/05/2011US20110105747 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
05/05/2011US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
05/05/2011US20110105542 Pyrazolo--quinazolines
05/05/2011US20110105541 ALKYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS
05/05/2011US20110105532 Haloalkyl-substituted amides as insecticides and acaricides
05/05/2011US20110105520 Pyrimidine compounds as delta opioid receptor modulators
05/05/2011US20110105492 ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS
05/05/2011US20110105329 Substituted Quinolinones Having Herbicidal Action
05/05/2011US20110105324 Herbicidal Compounds Based on N-Azinyl-N-Phenylsulfonylureas
05/05/2011CA2779120A1 Heterocyclyl substituted arylindenopy-rimidines and their use as highly selective adenosine a2a receptor antagonists
05/05/2011CA2779097A1 Aryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists
05/05/2011CA2778979A1 Phenoxy-substituted pyrimidines as opioid receptor modulators
05/05/2011CA2778219A1 Positive allosteric modulators (pam)
05/05/2011CA2777671A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
05/04/2011EP2316831A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
05/04/2011EP2316829A1 Heterocyclic derivatives as modulators of ion channels
05/04/2011EP2316828A1 Piperazine derivatives and their use as therapeutic agents
05/04/2011EP2315755A2 SYNTHESIS OF DIHYDROTHIENO[3,2-d]PYRIMIDINE DIOLS AND SIMILAR PYRIMIDINE DIOLS
05/04/2011EP2315754A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases
05/04/2011EP2315753A2 Material for organic photoelectric device and organic photoelectric device including the same
05/04/2011EP2044036B1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors
05/04/2011EP1660471B1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
05/04/2011EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors
05/04/2011CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound
05/04/2011CN102046609A Pyrimidine derivative having cell-protecting activity and use thereof
05/04/2011CN102046608A 3,4-dihydropyrimidine TRPA1 antagonists
05/04/2011CN102046605A Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
05/04/2011CN102046601A Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
05/04/2011CN102040521A Polymerizable compound
05/04/2011CN101235018B Modified method for preparing (1,4,5,6-tetrahydro-2-pyrimidyl)thiourea or salts thereof
05/04/2011CN101180278B 2-amino-4-phenylquinazoline derivates and their use as HSP90 modulators
05/04/2011CN101104608B Solanesol derivative, preparation and application thereof
05/04/2011CN101103005B Quinazoline derivatives, preparation methods and uses thereof
05/03/2011US7935852 Fluoridation method
05/03/2011US7935819 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
05/03/2011US7935711 Mixing of active material with carrier; viricides
05/03/2011US7935710 Microbicidal pyrimidine or triazine for preventing sexual HIV transmission
05/03/2011US7935707 Imidazole derivatives
05/03/2011US7935698 Heteroaryl-hydrazone compounds
05/03/2011US7935693 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
05/03/2011CA2528920C Cyclo(hetero)alkenyl compounds useful for treating pain
05/03/2011CA2495296C Process for preparing the calcium salt of rosuvastatin
05/03/2011CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/03/2011CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 427